Catalyst Wire Dossier Catalyst Wire Dossier

BRDE33-100

· BRPharm Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRDE33-100, covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of 'BRDE33-100' for the Temporary Correction of Moderate to Severe Nasolabial Folds [NA]

See pricing